Sort
21,453 grants matching “tuberculosis”
TB DRUG SCREENING:TB ANTIMICROBIAL ACQ &COORD. FACILITY
$778,162Southern Research Institute · N01 · FY2000 · AI
Promoting Adherence to TB Regimens in High-Risk Youth
$778,108Melbourne F Hovell · San Diego State University · R01 · FY2006 · HL
TUBERCULOSIS TECHNOLOGY TRANSFER SUPPORT
$778,049Research Triangle Institute · N01 · FY2000 · AI
Bacterial Determinants of TB Progression
$777,985David R Sherman · Seattle Biomedical Research Institute · U19 · FY2015 · AI
LPS Signaling in Macrophages: The Roll of Toll
$777,606Alan A Aderem · Seattle Children'S Hospital · R01 · FY2018 · AI
Bacterial Mechanisms and Host Pharmacokinetic Factors that Determine Persistence
$777,574Veronique Dartois · Rbhs-New Jersey Medical School · U19 · FY2019 · AI
Identifying TB transmitters in high TB/HIV burdened communities
$777,199Robin Wood · Desmond Tutu Hiv Foundation · R01 · FY2022 · AI
Identifying TB transmitters in high TB/HIV burdened communities
$777,199Robin Wood · Desmond Tutu Hiv Foundation · R01 · FY2021 · AI
Measuring Intralesional Drug Exposures in Cavitary TB using Noninvasive In Vivo PET Imaging
$777,071Sanjay Jain · Johns Hopkins University · R01 · FY2023 · AI
INHIBITION OF MYOCOLIC ACID BIOSYNTHESIS--M.TUBERCULOSIS
$776,978Yeshiva University · R01 · FY2002 · AI
Characterization of Genomics and Metabolomics among Individuals Highly-Exposed, but resistant to Mtb Infection
$776,825Neel Rajnikant Gandhi · Emory University · R01 · FY2022 · AI
Prevention and Treatment of Tuberculosis in the State of Oklahoma
$776,484Lauri Smithee · Oklahoma State Department Of Health · U52 · FY2010 · PS
Exploration, conservation, and development of marine bi*
$776,466Georgia Institute Of Technology · U01 · FY2005 · TW
A Biomedical Mass Spectrometry Resource: Ongoing Driving Biomedical Projects
$776,346Michael L Gross · Washington University · R24 · FY2021 · GM
Identifying Optimal Treatment Strategies for Tuberculosis Treatment
$776,254Radojka Savic · University Of California, San Francisco · R01 · FY2020 · AI
Efficacy of combination therapy in the Cynomolgus macaque model
$776,152Joanne L. Flynn · University Of Florida · P01 · FY2020 · AI
Treating Sleep Apnea in Type 2 Diabetes Mellitus: A Randomized Clinical Trial
$775,833Naresh Punjabi · Johns Hopkins University · R01 · FY2016 · HL
Dissecting the pathogenesis of HIV-TB Immune reconstitution inflammatory syndrome
$775,815Philana Ling Lin · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · AI
C-type Lectin Receptor Pathways in the Pathogenesis of TB/HIV Co-infection
$775,668Janice J Endsley · University Of Texas Med Br Galveston · R33 · FY2020 · AI
C-type Lectin Receptor Pathways in the Pathogenesis of TB/HIV Co-infection
$775,668Janice J Endsley · University Of Texas Med Br Galveston · R33 · FY2021 · AI
C-type Lectin Receptor Pathways in the Pathogenesis of TB/HIV Co-infection
$775,668Janice J Endsley · University Of Texas Med Br Galveston · R33 · FY2022 · AI
Molecular and single-cell immunology of myalgic encephalomyelitis/chronic fatigue syndrome
$775,509Ronald Wayne Davis · Stanford University · R01 · FY2018 · AI
The Bring BPaL2Me Trial - Comparing Nurse-Led RR-TB Treatment in Primary Care to Physician-Led, Hospital-Based RR-TB Treatment: A Cluster Randomized, Non-Inferiority Trial
$775,426Jason Edward Farley · Johns Hopkins University · R01 · FY2024 · AI
Characterization of Genomics and Metabolomics among Individuals Highly-Exposed, but resistant to Mtb Infection
$775,211Neel Rajnikant Gandhi · Emory University · R01 · FY2021 · AI
The effect of HIV exposure and infection on immunity to TB in children
$774,996Grace C John-Stewart · University Of Washington · R01 · FY2023 · AI